Clinical Research Institute Methodist Health System
Dallas, Texas, 75203, United States
Location status: Recruiting
Location contact
Crystee Cooper, DHEd
CONTACT
Kevin Burnham, PharmD
PRINCIPAL_INVESTIGATOR
CONTACT
NCT Number: NCT07486362
Patients are commonly discharged from the Emergency Department(ED) with pending blood culture results. Blood cultures can take up to 48 hours to become positive which is why it is important to notify patients with true positive cultures as soon as possible. Delay in notification can lead to other serious complications such as sepsis, septic shock, and death.
The American College of Emergency Physicians states pharmacists serve a critical role in ensuring efficient, safe, and effective medication use in the ED and advocates for health systems to support dedicated roles for pharmacists within the ED. Pharmacists help to decrease the workload on the healthcare team, especially in the ED where there is high volume and acuity.Emergency medicine pharmacist (EMP) play a significant role in the optimization of therapy, medication safety, and reducing costs.
There is strong evidence for the positive impact EMPs have on microbiological culture review. Overall, pharmacist review of late cultures results in higher rates of appropriate antimicrobial therapy and decreased missed interventions.These prior studies focused on the review of microbiological tests, including sexually transmitted infections, urine, and wound cultures; however, there was limited data to support the role of pharmacists evaluating late blood culture results.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Dallas, Texas, 75203, United States
Location status: Recruiting
Crystee Cooper, DHEd
CONTACT
Kevin Burnham, PharmD
PRINCIPAL_INVESTIGATOR
CONTACT
A multicenter retrospective study will be conducted at Methodist Charlton Medical Center (MCMC) and Methodist Dallas Medical Center (MDMC). The study will be conducted using the EMR to collect data from patients who were discharged and had pending blood cultures from the ED between July 1, 2022 to July 1, 2023. The variables to be collected from the Electronic medical record(EMR) are listed in Appendix B. All blood culture reviews at MCMC are reviewed, acted on, and documented by pharmacists during available hours. All blood cultures reviewed at MDMC are reviewed, acted on, and documented by charge nurses and physicians. The collection of data will begin after study approval is received by the Institutional review board(IRB).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No Intervention
Time frame: 18 months
Time to patient notification is defined as time until the first attempt to contact the patient regarding the actionable positive res
Contact information is provided by the study sponsor or research team.
Methodist Health System
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05721781
Bacteremia, Bacterial Infections
Boston, Massachusetts, United States
View Trial DetailsNCT06821282
Bacteremia, Bacterial Infections
Kinshasa, Kinshasa City, Democratic Republic of the Congo
View Trial DetailsNCT05770622
Bacteremia, Bacterial Infections
Melbourne, Victoria, Australia
View Trial DetailsNCT07134751
Bacteremia, Bacterial Infections
Gothenburg, Sweden
View Trial Details